Search results for: 'drug eluting b'

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

Drug device combination products are aimed to provide targeted treatment, enable better drug delivery and improve the efficacy of the device and medicine. This research service (RS) showcases some of these emerging drug-device combination products including drug eluting stents and drug loaded /coated orthopedic implants under implantable drug-devic...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

Robots are being used amidst of Covid-19 in performing various tasks , not limited to single operations, such as serving food and drinks, collecting dishes, collecting payment for customers. Robotics conveyors are enabled in fast food and sushi restaurants for catering high volume of orders while maintaining social distancing. Increasing purchase o...

11 Mar 2020  |  North America  |  Market Outlook

Global Homes and Buildings (H&B) Industry Outlook, 2020

Artificial Intelligence (AI)-driven Solutions, Energy Efficiency Directives, Sustainability Targets, Construction Activities, and Stringent Building Safety Codes Drive Overall Industry Growth

Infographics

×

Key Issues Addressed

The homes and buildings (H&B) industry is driven by the penetration of IoT at the field level of buildings, by the emerging adoption of artificial intelligence (AI)-driven solutions at the management level, and by cloud-based data analytics. These technologies are significantly impacting the smart homes, LED lighting, building automation, and build...

29 Apr 2019  |  Global  |  Market Outlook

Global Homes and Buildings (H&B) Industry Outlook, 2019

Artificial Intelligence (AI), Voice Command Control, and IoT-enabled Lighting to Drive the Industry Forward

Infographics

×

Key Issues Addressed

The homes and buildings (H&B) industry continues to evolve, driven by transformational technologies such as artificial intelligence (AI), machine learning, Internet of Things (IoT), data analytics, and the cloud. These technologies are significantly impacting smart homes, LED lighting, building automation, and building energy management markets. Ev...

15 Dec 2022  |  Global  |  Technology Research

Robotic Grippers: Technology Market Penetration and Roadmapping

New Product Development will meet requirements in manufacturing, healthcare, F&B, and pharmaceuticals.

Infographics

×

The growing global focus on the adoption of automation technologies and the high impact of industry 4.0 has led to the development of key enabling technology, such as robotic arms and grippers. This robotic gripper technology is a critical part of enabling the automation of mundane operations, such as pick and place, assembly, bin picking, and mach...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...